The interaction between the LXXLL motif and the AF-2 domain results in the AR-mediated gene transcription [8], thus the LXXLL motif is a high potential target to suppress PCa growth and overcome drug resistance in PCa [9,10]. The gene discussed is AR; the disease is posterior cortical atrophy.